LTRN Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own LTRN shares is 49, representing 24.1% of the company's common stock.

VANGUARD GROUP INC, in the last quarter, reduced its stake in LTRN by -0.44% restricting it's holding to 363.72 thousand shares of worth nearly $3.20M. MERIDIAN WEALTH MANAGEMENT, LLC also lessened -100% of the LTRN shares from its portfolio, reducing its holding to 0 shares of worth -. NEWEDGE ADVISORS, LLC also shunned LTRN shares holding by -3.28% last quarter which brought its holding to 160.53 thousand shares worth $1.41M.

As per its latest 13F filing, NORTHERN TRUST CORP increased its stake in LTRN by 1.83% in the last quarter. The institutional holder raised its holding to 12.82 thousand shares having worth more than $112.84K. RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. also added 100% more shares of LTRN to its portfolio, raising its holding to 12 thousand shares of worth $105.64K. AVANTAX PLANNING PARTNERS, INC. also increased its LTRN shares holding by 100% which brought its holding to 11.64 thousand shares worth $102.43K.

The insider with the most stakes in LTRN is Kreis Leslie W. , 10 percent owner at the company. Additionally, LTRN stock is highly held by 10 percent owner Fletcher Aaron G.L. and BP Directors, LP among others.

Company executives, directors, and other insiders own 14.74% percent of Lantern Pharma Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which LTRN insiders have sold stock, totaling 0 shares. Insiders that have sold shares include KREIS LESLIE W., FLETCHER AARON G.L., and BIOS ADVISORS GP, LLC.

There have been 0 transaction(s) during the past 6-months in which Lantern Pharma Inc. insiders have bought stock, totalling 0 shares

Around 0 Lantern Pharma Inc. shares are held by insiders, which represents about 14.74% of LTRN stock.

LTRN 10 percent owner, Kreis Leslie W. holds the largest portfolio of the company's shares. LTRN shares owned by Kreis total nearly 57.47 thousand.

VANGUARD GROUP INC is the largest institutional owner in LTRN which holds 363.72 thousand shares worth $3.20M or 3.35% of the total LTRN shares outstanding followed by NORTHERN TRUST CORP with ownership of 12.82 thousand shares representing 0.12% of the LTRN ownership. RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. is the third largest stakeholder with 12 thousand shares or 0.11% of the ownership worth more than $105.64K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the LTRN is concerned, it is a stock which is optionable.

Number of LTRN shares short is 176.91K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 10.78M shares of LTRN are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, LTRN has 7.94M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for LTRN is 4.74.